SEC Form 4 · accession 0001645627-17-000017
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Mar 17, 2017
Accepted (ET)
Mar 21, 2017 · 3:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 17, 2017 | P | 1,000 | $0.04 | A | 19,789,449 | D | |
| Common Stock | Mar 17, 2017 | P | 2,000 | $0.04 | A | 19,791,449 | D | |
| Common Stock | Mar 17, 2017 | P | 1,000 | $0.04 | A | 19,792,449 | D | |
| Common Stock | Mar 17, 2017 | P | 1,000 | $0.0397 | A | 19,793,449 | D | |
| Common Stock | Mar 17, 2017 | P | 1,000 | $0.0369 | A | 19,794,449 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.045 | A | 19,795,449 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.0465 | A | 19,796,449 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.0465 | A | 19,797,449 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.0468 | A | 19,798,449 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.0469 | A | 19,799,449 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.0479 | A | 19,800,449 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.052 | A | 19,801,449 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.054 | A | 19,802,449 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.05 | A | 19,803,449 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.0536 | A | 19,804,449 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.054 | A | 19,805,449 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.0545 | A | 19,806,449 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.055 | A | 19,807,449 | D | |
| Common Stock | Mar 20, 2017 | P | 200 | $0.054 | A | 19,807,649 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.0539 | A | 19,808,649 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.0538 | A | 19,809,649 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.053 | A | 19,810,649 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.053 | A | 19,811,649 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.0549 | A | 19,812,649 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.0549 | A | 19,813,649 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.0549 | A | 19,814,649 | D | |
| Common Stock | Mar 20, 2017 | P | 1,000 | $0.0556 | A | 19,815,649 | D | |
| Common Stock | Mar 21, 2017 | P | 1,000 | $0.0616 | A | 19,816,649 | D | |
| Common Stock | Mar 21, 2017 | P | 1,000 | $0.0548 | A | 19,817,649 | D |
Table II — derivative securities
No Table II lines on this filing.